Evidence map›Paper›PMID 26906411›Full record

ArticleStem cells and development2016

Development of Antiviral Innate Immunity During In Vitro Differentiation of Mouse Embryonic Stem Cells.

William D'Angelo, Dhiraj Acharya, Ruoxing Wang, Jundi Wang, Chandan Gurung, Bohan Chen, Fengwei Bai, Yan-Lin Guo

Open access · greenAbstract read
In one paragraph

Article in Stem cells and development, 2016. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 24 papers.

0numbers the graph read from it
0cells of the map it votes in
24citing papers in PubMed
1.7field-weighted citation impact, top 16% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

24 citing papers in PubMed, 31 citations in OpenAlex.

  1. Article
  2. Article
  3. Review
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Review
  12. Review
  13. Novel function ofIranian journal of basic medical sciences · 2021
    Article
  14. Review
  15. Article
  16. Article
  17. Review
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors at 1 institution in 1 country.

William D'Angelo1 Department of Biological Sciences, the University of Southern Mississippi , Hattiesburg, Mississippi.
Dhiraj Acharya1 Department of Biological Sciences, the University of Southern Mississippi , Hattiesburg, Mississippi.
Ruoxing Wang2 Department of Cancer Biology, University of Pennsylvania School of Medicine , Philadelphia, Pennsylvania.
Jundi Wang1 Department of Biological Sciences, the University of Southern Mississippi , Hattiesburg, Mississippi.
Chandan Gurung1 Department of Biological Sciences, the University of Southern Mississippi , Hattiesburg, Mississippi.
Bohan Chen1 Department of Biological Sciences, the University of Southern Mississippi , Hattiesburg, Mississippi.
Fengwei Bai1 Department of Biological Sciences, the University of Southern Mississippi , Hattiesburg, Mississippi.
Yan-Lin Guo1 Department of Biological Sciences, the University of Southern Mississippi , Hattiesburg, Mississippi.
University of Pennsylvania · US

Funding

Training and Mentoring Core P20GM103476 · NIGMS · UNIVERSITY OF SOUTHERN MISSISSIPPI · PI MICHAEL R GARRETT · 2012 to 2026
$60.2M
Embryonic stem cell-based fibroblast model of innate immunity developmentR15GM109299 · NIGMS · UNIVERSITY OF SOUTHERN MISSISSIPPI · PI GUO, YAN-LIN · 2014 to 2014
$354k
NIGMS NIH HHS 1R15GM109299-01A1NIGMS NIH HHS P20 GM103476NIGMS NIH HHS R15 GM109299
6 · The paper itself

Abstract

The innate immunity of embryonic stem cells (ESCs) has recently emerged as an important issue in ESC biology and in ESC-based regenerative medicine. We have recently reported that mouse ESCs (mESCs) do not have a functional type I interferon (IFN)-based antiviral innate immunity. They are deficient in expressing IFN in response to viral infection and have limited ability to respond to IFN. Using fibroblasts (FBs) as a cell model, the current study investigated the development of antiviral mechanisms during in vitro differentiation of mESCs. We demonstrate that mESC-differentiated FBs (mESC-FBs) share extensive similarities with naturally differentiated FBs in morphology, marker expression, and growth pattern, but their development of antiviral mechanisms lags behind. Nonetheless, the antiviral mechanisms are inducible during mESC differentiation as demonstrated by the transition of nuclear factor kappa B (NFκB), a key transcription factor for IFN expression, from its inactive state in mESCs to its active state in mESC-FBs and by increased responses of mESC-FBs to viral stimuli and IFN during their continued in vitro propagation. Together with our previously published study, the current data provide important insights into molecular basis for the deficiency of IFN expression in mESCs and the development of antiviral innate immunity during mESC differentiation.

Indexed as

Cell DifferentiationImmunity, InnateAnimalsCell LineChikungunya virusChlorocebus aethiopsCoculture TechniquesInterferon Type ILa Crosse virusMiceMouse Embryonic Stem CellsNF-kappa BRegenerative MedicineVero CellsInterferon Type INF-kappa B

Identifiers

PMID26906411
PMCPMC4834518
OpenAlexW2277396401

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.